Interpreting | 2007.03.13
Inflazyme Announces Outcome of Review of Phase 2b Asthma Study ... - PharmaLive.com (press release)
| Inflazyme Announces Outcome of Review of Phase 2b Asthma Study ... PharmaLive.com (press release), PA - However, taken together, we believe these issues nullify interpretation of the Phase 2b study. Inflazyme believes that IPL512,602 would benefit from ... Inflazyme cites placebo oddities in disappointing asthma drug study |
For more information, please visit
http://news.google.com/news/url?sa=T&ct=[...]categoryid%3D40&cid=1114403718
